Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 30, 2023
Dec. 31, 2022
Current Assets    
Cash $ 171.7 $ 78.4
Accounts receivable, less allowance for credit losses of $3.6 and $4.6 as of December 30, 2023 and December 31, 2022, respectively 174.1 155.4
Contract assets 49.7 39.3
Inventories 48.4 67.7
Prepaid expenses 8.4 9.1
Other current assets 10.8 13.3
Total current assets 463.1 363.2
Right of-use assets, net 50.9 44.3
Property, plant and equipment, net 52.4 42.1
Intangible assets, net 375.3 404.4
Goodwill 368.6 368.2
Deferred tax asset, net 36.8 46.6
Other assets 2.9 1.8
Total assets 1,350.0 1,270.6
Current Liabilities    
Accounts payable 59.8 52.3
Billings in excess of costs 26.7 21.4
Current maturities of long-term debt 7.3 8.3
Accrued expenses and other current liabilities 80.3 70.6
Total current liabilities 174.1 152.6
Long-term debt, net 607.7 699.9
Deferred tax liability, net 1.7 1.9
Other long-term liabilities 46.9 40.9
Total liabilities 830.4 895.3
Commitments and Contingencies (Note 20)
STOCKHOLDERS’ EQUITY    
Common Stock, 825,000,000 shares authorized, $0.0001 par value, 146,861,489 and 146,703,894 shares issued and outstanding at December 30, 2023 and December 31, 2022, respectively 0.0 0.0
Treasury stock, at cost, 34,297 and zero shares at December 30, 2023 and December 31, 2022, respectively (0.4) 0.0
Additional paid in capital 289.0 281.9
Accumulated other comprehensive loss (2.9) (4.8)
Retained earnings 233.9 98.2
Total stockholders’ equity 519.6 375.3
Total liabilities and stockholders’ equity $ 1,350.0 $ 1,270.6